Oracle (ORCL)
(Real Time Quote from BATS)
$114.31 USD
-1.03 (-0.89%)
Updated Apr 25, 2024 09:41 AM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Price, Consensus and EPS Surprise
orcl 114.31 -1.03(-0.89%)
Will orcl be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for orcl based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for orcl
Oracle Corporation (ORCL) Is a Trending Stock: Facts to Know Before Betting on It
Oracle (ORCL) Gains But Lags Market: What You Should Know
orcl: What are Zacks experts saying now?
Zacks Private Portfolio Services
Microsoft's (MSFT) Azure Cloud Prowess to Boost Q3 Earnings
Oracle (ORCL) Helps Reka Power Generative AI Innovation
Oracle (ORCL) to Invest More Than $8B in Cloud Computing & AI
Other News for orcl
ByteDance mulls scenarios to sell TikTok without algorithm - report
C3.ai Is Undervalued, but Will Face Profitability Pressures
Oracle U.S. Government Cloud Customers Accelerate Sovereign AI with NVIDIA AI Enterprise
Oracle Helps Federal Agencies Optimize Finance in the Cloud
Oracle Targets Nashville for New Global HQ, Aiming to Enhance Healthcare Focus